Commercial Demand for Microgravity Drug Discovery Accelerates as Exobiosphere and Voyager Add Two Missions to the ISS
DENVER & HOUSTON--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) and Exobiosphere today announced two additional research campaigns aboard the International Space Station, expanding an agreement that is turning commercial biotech research in microgravity into a recurring, schedulable service rather than a one-off opportunity. Exobiosphere’s Orbital High-Throughput Screening in Microgravity (OHTS) platform, a mid-deck-locker-class system for automated drug screening, is scheduled for install